Related Experiment Video
Updated: Sep 30, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Altered Mucosal Immune-Microbiota Interactions in Familial Adenomatous Polyposis
Alistair Noble1,2, Lydia Durant2, Stella M Dilke2
1Gut Microbes and Health Program, Quadram Institute Bioscience, Norwich, United Kingdom.
Familial adenomatous polyposis (FAP) patients show reduced T cells in the colon, indicating immune dysfunction. This may contribute to colorectal cancer development in this genetic condition.
Area of Science:
- Gastroenterology
- Immunology
- Oncology
Background:
- Familial adenomatous polyposis (FAP) is a genetic disorder leading to colorectal cancer.
- The role of mucosal immunity in FAP-associated tumorigenesis is not fully understood.
Purpose of the Study:
- To investigate the interaction between the mucosal immune system and gut bacteria in FAP.
- To identify potential immune dysfunctions that accelerate tumor formation in FAP.
Main Methods:
- Colonic biopsies from FAP patients and healthy controls were analyzed.
- Intraepithelial and lamina propria lymphocytes were phenotyped.
- Epithelial-associated microbes were analyzed for IgA/IgG coating.
Main Results:
- Reduced CD8+ and gamma delta T cells in the colonic mucosa of FAP patients.
- Altered T cell marker expression (CD103, CD73) in FAP lamina propria.
- Increased IgA coating of bacteria and heightened immune responses to commensals in FAP.
Conclusions:
- FAP involves mucosal immune dysfunction, including loss of resident memory T cells.
- This immune impairment may contribute to barrier dysfunction and colorectal cancer development.
- Findings suggest critical pathways in the etiology of FAP-driven colorectal cancer.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: